From 23 June 2025, people living with obesity and four or more diagnosed health
conditions will begin to have the opportunity to access tirzepatide (Mounjaro®) for weight
loss support through their GP. This process will be managed
through the practice directly contacting people who are eligible, this does not mean that
prescriptions will be given out immediately. We will be contacting people who have
been identified as eligible over the coming weeks.
Access to the medication goes hand in hand with support to help with eating habits and
start/improve physical activity as part of a national wrap around service. Access to
prescribed weight loss medication will be predicated on a patients engagement with this
service.
Full qualifying criteria is a BMI (Body Mass Index) of 40 or greater and four or more of the
following diagnosed health conditions:
• type 2 diabetes
• Hypertension
• Cardiovascular disease
• Obstructive sleep apnoea
• Dyslipidaemia
We understand that some people may feel frustrated or disappointed if they are not eligible
for medication-based treatments at this stage. Living with obesity can be emotionally and
physically challenging, and it is completely normal to experience a range of feelings when
seeking support for your health. If you are finding things difficult, NHS Talking Therapies
offers free and confidential help for people who may be struggling with low mood, anxiety
or other emotional pressures.
To find out more about obesity treatment and the support available on the NHS Sussex Website
You can also read the following for more information:
• NHS England » Weight management injections – NHS England has published a set of FAQs in relation to Mounjaro.